MedPath

Parkinson's Disease Registry of the Muhammad Ali Parkinson Center

Conditions
Parkinson's Disease
Registration Number
NCT00217321
Lead Sponsor
Muhammad Ali Parkinson Research Center
Brief Summary

The purpose of the Parkinson's disease Registry is to develop a national and international database of persons with Parkinson's disease (PD). The Registry will be used to facilitate the development of new therapies and healthcare services to improve the quality of life for people with PD. It will also be a means for investigators in the field of PD to quickly identify and notify subjects about other research studies for which they are eligible.

Objectives include:

* Assess current treatment approaches and develop best-practice guidelines

* Track the functional abilities, access to healthcare and cost of illness of people with PD over time

* Drive the development of innovative research projects

* Accelerate the process of informing patients of research projects for which they may be eligible

Detailed Description

What do you need to know?

* Any individual diagnosed with PD is eligible to enroll.

* Participation in the registry is voluntary, confidential and free of charge.

* Eligible participants will be notified about opportunities to participate in clinical trials, though they are under no obligation to enter.

* Participants will need to complete an updated questionnaire every six months.

* Participants may also be asked to complete additional surveys for PD research projects.

* Any data provided will be used in scientific publications in summary form only.

* Participant names will not be released to anyone outside the Parkinson's disease Registry management team without written authorization, nor will names be sold for advertising or fund-raising purposes.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
20000
Inclusion Criteria
  • Clinical diagnosis of Parkinson's disease
Exclusion Criteria
  • No clinical diagnosis of Parkinson's disease

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Muhammad Ali Parkinson Research Center

🇺🇸

Phoenix, Arizona, United States

© Copyright 2025. All Rights Reserved by MedPath